Kaiser Martina, Haag Jochen, Söder Stephan, Bau Brigitte, Aigner Thomas
Osteoarticular and Artheritis Research, Dept, or Pathology, University of Erlangen-Nuremberg, Krankenhausstrasse 8-10, 91054 Erlangen, Germany.
Arthritis Rheum. 2004 Nov;50(11):3535-40. doi: 10.1002/art.20750.
Bone morphogenetic protein (BMP) and transforming growth factor beta (TGFbeta) are potent anabolic factors in adult articular chondrocytes. In this study, we investigated whether intracellular inhibitors of BMP and TGFbeta signaling, inhibitory Smad6 (I-Smad6) and I-Smad7, are expressed in articular chondrocytes in normal and osteoarthritic (OA) cartilage, and whether their expression shows a correlation with the anabolic activity of OA chondrocytes in vivo and after interleukin-1beta (IL-1beta) stimulation in vitro.
RNA isolated directly from normal and OA human knee cartilage as well as from cultured articular chondrocytes was analyzed by (quantitative) polymerase chain reaction technology. Immunolocalization of the I-Smads was performed on tissue sections and compared with the anabolic cellular activity as documented by in situ hybridization experiments for aggrecan and type II collagen.
Both Smad6 and Smad7 were expressed in all samples of normal and OA cartilage. Immunostaining (including confocal microscopy) confirmed the presence of Smad6 and Smad7 in the majority of normal and degenerated articular chondrocytes; localization was mostly cytoplasmic. No correlation between expression of the main anabolic genes and expression of the I-Smads was found. In cultured articular chondrocytes, stimulation with IL-1beta showed up-regulation of Smad7, whereas Smad6 was down-regulated.
Both Smad6 and Smad7 are expressed in adult human articular chondrocytes. The primarily cytoplasmic localization suggests permanent activation of the I-Smads in articular cartilage in vivo. No evidence was found that up-regulation or down-regulation of I-Smads in OA cartilage correlates directly with the anabolic (or catabolic) activity of articular chondrocytes. The regulation in chondrocytes of Smad6 and Smad7 expression by IL-1beta suggests a potentially important role of IL-1beta signaling in chondrocytes, via indirect influencing of the BMP/TGFbeta signaling cascade.
骨形态发生蛋白(BMP)和转化生长因子β(TGFβ)是成年关节软骨细胞中强大的合成代谢因子。在本研究中,我们调查了BMP和TGFβ信号通路的细胞内抑制剂,即抑制性Smad6(I-Smad6)和I-Smad7,在正常和骨关节炎(OA)软骨的关节软骨细胞中是否表达,以及它们的表达是否与OA软骨细胞在体内的合成代谢活性以及体外白细胞介素-1β(IL-1β)刺激后的活性相关。
通过(定量)聚合酶链反应技术分析直接从正常和OA人膝关节软骨以及培养的关节软骨细胞中分离的RNA。对组织切片进行I-Smads的免疫定位,并与通过聚集蛋白聚糖和II型胶原原位杂交实验记录的合成代谢细胞活性进行比较。
Smad6和Smad7在正常和OA软骨的所有样本中均有表达。免疫染色(包括共聚焦显微镜检查)证实大多数正常和退变的关节软骨细胞中存在Smad6和Smad7;定位大多在细胞质中。未发现主要合成代谢基因的表达与I-Smads的表达之间存在相关性。在培养的关节软骨细胞中,IL-1β刺激显示Smad7上调,而Smad6下调。
Smad6和Smad7均在成年人类关节软骨细胞中表达。主要的细胞质定位表明体内关节软骨中I-Smads处于永久激活状态。没有证据表明OA软骨中I-Smads的上调或下调与关节软骨细胞的合成代谢(或分解代谢)活性直接相关。IL-1β对软骨细胞中Smad6和Smad7表达的调节表明,IL-1β信号通路通过间接影响BMP/TGFβ信号级联反应,在软骨细胞中可能发挥重要作用。